Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Clinical Microbiology|July 10, 2004
Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profilesAbdolreza Advani, Declan Donnelly, Hans HallanderVaccine|August 2, 2005
Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse modelPhilippe Denoël, Fabrice Godfroid, Nicole Guiso, et al.Expert Review of Vaccines|November 3, 2011
Glycoconjugate vaccines and immune interactions, and implications for vaccination schedulesRay Borrow, Ron Dagan, Fred Zepp, et al.Vaccine|November 19, 2011
Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillanceLennart Nilsson, Tiia Lepp, Kerstin von Segebaden, et al.Vaccine|October 13, 2006
Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination historiesAnnika Elomaa, Abdolreza Advani, Declan Donnelly, et al.Journal of Clinical Microbiology|August 6, 2005
Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 yearsAnnika Elomaa, Abdolreza Advani, Declan Donnelly, et al.Scandinavian Journal of Infectious Diseases|April 11, 2003
Legionella pneumophila serogroup 1 antibody kinetics in patients with Legionnaires' disease: implications for serological diagnosisJohan Darelid, Sture Löfgren, Bo-Eric Malmvall, et al.Journal of Clinical Microbiology|May 6, 2005
Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methodsRaymond S W Tsang, Michelle L Sill, Abdolreza Advani, et al.Clinical and Vaccine Immunology : CVI|December 6, 2013
Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007Hans Hallander, Abdolreza Advani, Frances Alexander, et al.Journal of Theoretical Biology|April 29, 2014
Modeling rates of infection with transient maternal antibodies and waning active immunity: application to Bordetella pertussis in SwedenZhilan Feng, John W Glasser, Andrew N Hill, et al.Pageof 2